Results

Total Results: 323 records

Showing results for "malignant neoplasm".

201. Nis 1999 Summarystats Core10B (pdf file)
     hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_1999_SummaryStats_CORE10B.PDF
     January 01, 1999 - cancer of skin 128 0.02 24: Cancer of breast 2507 0.35 25: Cancer of uterus 815 0.11 26: Cancer of … : Cancer of prostate 2126 0.30 30: Cancer of testis 40 0.01 31: Cancer of other male genital organs … , other Unspecified primary 192 0.03 42: Secondary malignancies 5080 0.71 43: Malignant neoplasm without … 45: Maintenance chemotherapy, radiotherapy 3650 0.51 46: Benign neoplasm of uterus 4972 0.69 47: Other … unspecified benign neoplasm 3463 0.48 48: Thyroid disorders 742 0.10 49: Diabetes mellitus without

202. Nis 1998 Summarystats Core10B (pdf file)
     hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_1998_SummaryStats_CORE10B.PDF
     January 01, 1998 - cancer of skin 149 0.02 24: Cancer of breast 2373 0.35 25: Cancer of uterus 692 0.10 26: Cancer of … : Cancer of prostate 1786 0.26 30: Cancer of testis 31 0.00 31: Cancer of other male genital organs … , other Unspecified primary 246 0.04 42: Secondary malignancies 5283 0.77 43: Malignant neoplasm without … 45: Maintenance chemotherapy, radiotherapy 3740 0.55 46: Benign neoplasm of uterus 4354 0.64 47: Other … unspecified benign neoplasm 2870 0.42 48: Thyroid disorders 681 0.10 49: Diabetes mellitus without

203. Nis 1999 Summarystats (pdf file)
     hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_1999_SummaryStats.PDF
     January 01, 1999 - cancer of skin 1315 0.02 24: Cancer of breast 24405 0.34 25: Cancer of uterus 7566 0.11 26: Cancer … 29: Cancer of prostate 20728 0.29 30: Cancer of testis 393 0.01 31: Cancer of other male genital … , other Unspecified primary 1858 0.03 42: Secondary malignancies 50461 0.70 43: Malignant neoplasm … 0.12 45: Maintenance chemotherapy, radiotherapy 36883 0.51 46: Benign neoplasm of uterus 48732 0.68 … 47: Other unspecified benign neoplasm 34867 0.48 48: Thyroid disorders 7555 0.10 49: Diabetes mellitus

204. Nis 1999 Summarystats Core10A (pdf file)
     hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_1999_SummaryStats_CORE10A.pdf
     January 01, 1999 - cancer of skin 150 0.02 24: Cancer of breast 2403 0.33 25: Cancer of uterus 755 0.10 26: Cancer of … : Cancer of prostate 2035 0.28 30: Cancer of testis 45 0.01 31: Cancer of other male genital organs … , other Unspecified primary 193 0.03 42: Secondary malignancies 5023 0.70 43: Malignant neoplasm without … 45: Maintenance chemotherapy, radiotherapy 3634 0.50 46: Benign neoplasm of uterus 4924 0.68 47: Other … unspecified benign neoplasm 3469 0.48 48: Thyroid disorders 773 0.11 49: Diabetes mellitus without

205. Microsoft Word - CaseforPOAIndicator_final_060806 _2_.doc (pdf file)
     hcup-us.ahrq.gov/reports/methods/2006_1.pdf
     January 01, 2006 - For example, if a patient presents with a lump and it is diagnosed as a malignant neoplasm during the … hospitalization, the malignant neoplasm should be considered to be present on admission. … For example, “personal history of malignant neoplasm” cannot develop after admission. … Neoplasm Bronchus or Lung 11,303 11,244 99.48 1,311 1,302 99.3% 174.9 Malignant Neoplasm Breast 4,735 … 4,724 99.77 960 952 99.2% 185 Malignant Neoplasm Prostate 14,486 14,438 99.67 4,855 4,781 98.5% 250.00

206. Maskedstats Nis 2015Q1Q3 Severity (pdf file)
     hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2015Q1Q3_Severity.PDF
     November 08, 2017 - electrolyte disorders 5,377,720 0 0.00 1.00 0.22 0.42 CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 5,377,720 0 0.00 1.00 0.11 0.32 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 3,979 0.07% 110: Ear, nose, mouth, throat, cranial/facial malignancies … 2,580 0.05% 681: Other O.R. procedures for lymphatic/hematopoietic/other neoplasms 3,152 0.06% 690 … & neoplasms of uncertain behavior 3,745 0.07% 710: Infectious & parasitic diseases including HIV w

207. Nis 2014 Maskedstats Severity (pdf file)
     hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2014_MaskedStats_Severity.PDF
     January 01, 2014 - Variable / Label N N Miss Minimum Maximum Mean Std Dev CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 7,071,762 0 0.00 1.00 0.11 0.31 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 5,370 0.08% 110: Ear, nose, mouth, throat, cranial/facial malignancies … 3,499 0.05% 681: Other O.R. procedures for lymphatic/hematopoietic/other neoplasms 4,365 0.06% 690 … Percent of Total 692: Radiotherapy 586 0.01% 693: Chemotherapy 29,695 0.42% 694: Lymphatic & other malignancies

208. Kid 2012 Maskedstats Severity (pdf file)
     hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2012_MaskedStats_Severity.PDF
     January 01, 2012 - electrolyte disorders 3,195,782 0 0.00 1.00 0.08 0.27 CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 3,195,782 0 0.00 1.00 0.00 0.06 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 4,907 0.15% 110: Ear, nose, mouth, throat, cranial/facial malignancies … for APRDRG APRDRG Frequency Percent of Total 693: Chemotherapy 32,305 1.01% 694: Lymphatic & other malignancies … & neoplasms of uncertain behavior 475 0.01% 710: Infectious & parasitic diseases including HIV w O.R

209. Nis 2013 Maskedstats Severity (pdf file)
     hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2013_MaskedStats_Severity.PDF
     January 01, 2013 - Variable / Label N N Miss Minimum Maximum Mean Std Dev CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 7,119,563 0 0.00 1.00 0.10 0.30 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 5,780 0.08% 110: Ear, nose, mouth, throat, cranial/facial malignancies … 3,581 0.05% 681: Other O.R. procedures for lymphatic/hematopoietic/other neoplasms 4,512 0.06% 690 … Percent of Total 692: Radiotherapy 664 0.01% 693: Chemotherapy 30,425 0.43% 694: Lymphatic & other malignancies

210. Maskedstats Nrd 2015Q1Q3 Severity (pdf file)
     hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2015Q1Q3_Severity.PDF
     October 31, 2017 - electrolyte disorders 12,927,179 0 0.00 1.00 0.24 0.43 CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 12,927,179 0 0.00 1.00 0.12 0.33 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 9,988 0.08% 110: Ear, nose, mouth, throat, cranial/facial malignancies … 6,987 0.05% 681: Other O.R. procedures for lymphatic/hematopoietic/other neoplasms 8,696 0.07% 690 … Percent of Total 692: Radiotherapy 855 0.01% 693: Chemotherapy 53,580 0.41% 694: Lymphatic & other malignancies

211. Nrd 2014 Maskedstats Severity (pdf file)
     hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2014_MaskedStats_Severity.PDF
     January 01, 2014 - electrolyte disorders 14,894,613 0 0.00 1.00 0.23 0.42 CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 14,894,613 0 0.00 1.00 0.12 0.32 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 11,999 0.08% 110: Ear, nose, mouth, throat, cranial/facial malignancies … Percent of Total 692: Radiotherapy 1,074 0.01% 693: Chemotherapy 63,030 0.42% 694: Lymphatic & other malignancies … & neoplasms of uncertain behavior 11,821 0.08% 710: Infectious & parasitic diseases including HIV w

212. Nis 2012 Maskedstats Severity (pdf file)
     hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2012_MaskedStats_Severity.PDF
     January 01, 2012 - Variable / Label N N Miss Minimum Maximum Mean Std Dev CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 7,296,968 0 0.00 1.00 0.10 0.30 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 5,994 0.08% 110: Ear, nose, mouth, throat, cranial/facial malignancies … 3,605 0.05% 681: Other O.R. procedures for lymphatic/hematopoietic/other neoplasms 4,755 0.07% 690 … Percent of Total 692: Radiotherapy 706 0.01% 693: Chemotherapy 31,632 0.43% 694: Lymphatic & other malignancies

213. Nis 1998 Summarystats Core10A (pdf file)
     hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_1998_SummaryStats_CORE10A.PDF
     January 01, 1998 - cancer of skin 122 0.02 24: Cancer of breast 2353 0.34 25: Cancer of uterus 753 0.11 26: Cancer of … : Cancer of prostate 1733 0.25 30: Cancer of testis 37 0.01 31: Cancer of other male genital organs … , other Unspecified primary 186 0.03 42: Secondary malignancies 5145 0.75 43: Malignant neoplasm without … 45: Maintenance chemotherapy, radiotherapy 3772 0.55 46: Benign neoplasm of uterus 4448 0.65 47: Other … unspecified benign neoplasm 2893 0.42 48: Thyroid disorders 715 0.10 49: Diabetes mellitus without

214. User Guide (v2025.1) for Clinical Classifications Software Refined (CCSR) for ICD-10-CM (pdf file)
     hcup-us.ahrq.gov/toolssoftware/ccsr/DXCCSR-User-Guide-v2025-1.pdf
     November 01, 2024 - status, and Z19.2, Hormone resistant malignancy status, to CCSR category NEO071 (Malignant neoplasm … Neoplasms NEO NEO contains 78 categories specific to neoplasms, which include malignant neoplasms … such as gastrointestinal cancers, skin cancers, and breast cancer, as well as most benign neoplasms … The Neoplasms body system follows the National Cancer Institute (NCI)8 organization of cancer types … status, and Z19.2, Hormone resistant malignancy status, to CCSR category NEO071 (Malignant neoplasm

215. ___APS-Def_Public.book (pdf file)
     hcup-us.ahrq.gov/db/nation/nis/APS-Def_Public_v24.pdf
     March 01, 2008 - PROCS 172 172 DIGESTIVE MALIGNANCY 173 172 DIGESTIVE MALIGNANCY 174 174 G.I. … PROC 202 205 DISORDERS OF LIVER, EX MALIGNANCY 203 203 MALIGNANCY OF HEPATOBIL SYST OR PANCREAS 204 … 204 DISORDERS OF PANCREAS EXCEPT MALIGNANCY 205 205 DISORDERS OF LIVER, EX MALIGNANCY 206 205 DISORDERS … 258 CDRG EXCL 259 MASTECTOMY FOR MALIGNANCY 259 CDRG EXCL 259 MASTECTOMY FOR MALIGNANCY 260 CDRG … PROCS EX MALIG 346 346 MALIGNANCY, MALE REPRO SYSTEM, 347 346 MALIGNANCY, MALE REPRO SYSTEM, 348

216. Icd-10 Dxccs Trends112817 (pdf file)
     hcup-us.ahrq.gov/datainnovations/ICD-10_DXCCS_Trends112817.pdf
     November 28, 2017 - 0.8 –2.9 43: Malignant neoplasm without specification of site 1,064 1,072 1,308 0.8 22.0 44: … 18,167 22,433 8.4 23.5 43: Malignant neoplasm without specification of site 4,728 4,931 3,062 4.3 … 45: Maintenance chemotherapy; radiotherapy 500 606 834 21.2 37.6 46: Benign neoplasm of uterus … 15,610 17,381 17,512 11.3 0.8 47: Other and unspecified benign neoplasm 20,852 23,784 22,214 14.1 … of pancreas 2,592 2,994 3,019 15.5 0.8 46: Benign neoplasm of uterus 15,610 17,381 17,512 11.3 0.8

217. ___APS-Def_Public.book (pdf file)
     hcup-us.ahrq.gov/db/nation/nis/APS-DRGs%20V23%20Definitions%20Manual.pdf
     August 01, 2006 - PROCS 172 172 DIGESTIVE MALIGNANCY 173 172 DIGESTIVE MALIGNANCY 174 174 G.I. … PROC 202 205 DISORDERS OF LIVER, EX MALIGNANCY 203 203 MALIGNANCY OF HEPATOBIL SYST OR PANCREAS 204 … 204 DISORDERS OF PANCREAS EXCEPT MALIGNANCY 205 205 DISORDERS OF LIVER, EX MALIGNANCY 206 205 DISORDERS … 258 CDRG EXCL 259 MASTECTOMY FOR MALIGNANCY 259 CDRG EXCL 259 MASTECTOMY FOR MALIGNANCY 260 CDRG … PROCS EX MALIG 346 346 MALIGNANCY, MALE REPRO SYSTEM, 347 346 MALIGNANCY, MALE REPRO SYSTEM, 348

218. Clinical Classifications for Health Policy Research: Hospital Inpatient Statistics, 1995
     hcup-us.ahrq.gov/reports/natstats/his95/appaa.htm
     September 01, 1998 - 20260 20261 20262 20263 20264 20265 20266 20267 20268 2340 2348 2349 7951 42 Secondary malignancies … 1975 1976 1977 1978 1980 1981 1982 1983 1984 1985 1986 1987 19881 19882 19889 43 Malignant … neoplasm without specification of site 1990 1991 44 Neoplasms of unspecified nature or uncertain … 2399 45 Maintenance chemotherapy, radiotherapy V580 V581 V661 V662 V671 V672 46 Benign … benign neoplasm V1272 2100 2101 2102 2103 2104 2105 2106 2107 2108 2109 2110 2111

219. Microsoft Word - APS_DRG_Def_Public_V21.doc (pdf file)
     hcup-us.ahrq.gov/db/nation/nis/APS-DRGs%20V21%20Weights%20Manual.pdf
     January 06, 2025 - Procedure): CDRG 400 in MDC 17 (Myeloproliferative Diseases and Disorders and Poorly Differentiated Neoplasms … MDC 17 – MYELOPROLIFERATIVE DISEASES AND DISORDERS AND POORLY DIFFERENTIATED NEOPLASMS: The logic … Malignancy Codes: Diagnosis code V10.48 (history of malignancy, epididymis) is now included as a history … of malignancy code within CDRG 465 (Aftercare With History of Malignancy as Secondary Diagnosis). … MDC 17 (Myeloproliferative Diseases and Disorders and Poorly Differentiated Neoplasms): CDRG 539 (Lymphoma

220. ___APS-Def_Public.book (pdf file)
     hcup-us.ahrq.gov/db/nation/nis/APS-DRGs%20V22%20Definitions%20Manual.pdf
     April 01, 2006 - PROCS 172 172 DIGESTIVE MALIGNANCY 173 172 DIGESTIVE MALIGNANCY 174 174 G.I. … PROC 202 205 DISORDERS OF LIVER, EX MALIGNANCY 203 203 MALIGNANCY OF HEPATOBIL SYST OR PANCREAS 204 … 204 DISORDERS OF PANCREAS EXCEPT MALIGNANCY 205 205 DISORDERS OF LIVER, EX MALIGNANCY 206 205 DISORDERS … 259 CDRG EXCL 259 MASTECTOMY FOR MALIGNANCY 260 CDRG EXCL 259 MASTECTOMY FOR MALIGNANCY 261 261 … PROCS EX MALIG 346 346 MALIGNANCY, MALE REPRO SYSTEM, 347 346 MALIGNANCY, MALE REPRO SYSTEM, 348